Universitätsmedizin Rostock

Rostock D-18065

2 studies enrolling now · 11 studies all time

What they study most

Acute Alcoholic Hepatitis, Atrial Fibrillation, CIED Related Infection, Carcinoma, Transitional Cell, Heart Failure, Kidney Disease, Chronic, Neoplasm Metastasis, Parkinson's Disease, Percutaneous Coronary Intervention, Post-essential Thrombocythemia Myelofibrosis, Post-polycythemia Vera Myelofibrosis, Primary Myelofibrosis

Studies at this site

• A Study of Vepugratinib (LY3866288) in Participants With Cancer in the Urinary Tract — Recruiting now
• EASi-KIDNEY™ (The Studies of Heart & Kidney Protection With BI 690517 in Combination With Empagliflozin) — Recruiting now
• Evaluation of Long Term Safety and Efficacy of Glepaglutide in Treatment of SBS - Extension Trial — Running, not enrolling
• Evaluation of Long Term Safety and Efficacy of Glepaglutide in Treatment of SBS — Running, not enrolling
• Efficacy And Safety Evaluation of Glepaglutide in Treatment of Short Bowel Syndrome (SBS) — Completed
• Study to Assess Efficacy and Safety of NS-018 Compared to BAT in Patients With Myelofibrosis — Stopped early
• Noninterventional Study Evaluating Parkinson's Disease Diary Use — Running, not enrolling
• World-wide Randomized Antibiotic Envelope Infection Prevention Trial — Completed
• Randomized, Open-Label, Multicenter, Controlled, Pivotal Study to Assess Safety and Efficacy of ELAD in Subjects w/ AILD — Stopped early
• Evaluation of Dual Therapy With Dabigatran vs. Triple Therapy With Warfarin in Patients With AF That Undergo a PCI With Stenting (REDUAL-PCI) — Completed
• Safety and Clinical Performance of the Protecta ICD and CRT-D — Completed